AKRX News Alert Akorn Inc (AKRX) 37.68 11/13/2014 16:17:55

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 37.68 $AKRX

Stocks Rally Back After Midday Sell-Off
at Investor's Business Daily - Thu Nov 13, 12:17PM CST
Stocks were trying to recover after a midday sell-off lopped off most of the morning gains. The Nasdaq rose 0.3%, the S&P 500 was flat and the Dow Jones industrial average was up 0.2%. Volume was running at a higher pace than at the same time...
DDS: 112.76 (+3.35), AKRX: 37.68 (+2.25), WMT: 82.94 (+3.74), THRM: 40.13 (-0.93)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ICUI: 84.95 (+0.22), AKRX: 37.68 (+2.25), WPC: 66.65 (+0.25), FLWS: 9.01 (-0.02), MMSI: 15.04 (-0.36)

Stocks Open With Mild Losses; American Eagle, Macys Jump
at Investor's Business Daily - Wed Nov 12, 9:35AM CST
Stocks opened to mild losses in mixed trade Wednesday, as company earnings reports fueled much of the early action. The Dow Jones industrial average and the S&P 500 each dipped 0.2%. The Nasdaq shed a bit less than 0.1%. The stock market today got...
AMBA: 47.74 (-1.65), AKRX: 37.68 (+2.25), AEO: 13.58 (-0.22), M: 61.57 (unch), FANG: 64.76 (-0.05)

Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Mon Nov 10, 5:02PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.02 to a high of $36.36. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $35.04 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 37.68 (+2.25)

Akorn (AKRX) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:19AM CST
Akorn (AKRX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AKRX: 37.68 (+2.25)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.19 (-0.01), LCI: 48.28 (-1.45), AKRX: 37.68 (+2.25), AFSI: 52.16 (+0.42), EXPE: 86.49 (-0.62), FFIV: 126.15 (+0.39), SLXP: 96.99 (+1.44), MPWR: 44.87 (-0.51), TMH: 53.91 (+0.13), ATHM: 42.99 (-0.01)

Stocks In Retreat After Jobs Report; Monster Beverage Gains
at Investor's Business Daily - Fri Nov 07, 9:31AM CST
jobs report, Arista Networks earnings, leading stocks, Monster Beverage stock, breakout stocks Stocks opened lower Friday after disappointing gains in October payrolls. The Nasdaq slumped 0.4% due to weakness in networking, biotech and solar issues....
MNST: 108.16 (+0.25), ANET: 76.97 (-0.27), AKRX: 37.68 (+2.25), ATHM: 42.99 (-0.01)

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.19 (-0.01), HD: 99.00 (+0.51), AKRX: 37.68 (+2.25), ILMN: 185.00 (-1.92)

SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 37.68 (+2.25)

Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 76.47 (-0.38), SWIR: 38.96 (+1.66), AAP: 146.00 (-0.27), AKRX: 37.68 (+2.25), BABA: 114.84 (-3.36)

Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:17PM CST

AKRX: 37.68 (+2.25)

Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 37.68 (+2.25)

Stocks Up Slightly After Choppy Action
at Investor's Business Daily - Thu Nov 06, 12:26PM CST
Stocks were modestly higher after struggling for direction earlier. Overall, equities have wavered Thursday amid news of potential stimulus by the European Central Bank and better-than-expected data on jobless claims and productivity. The Dow Jones...
GPRO: 76.47 (-0.38), SWIR: 38.96 (+1.66), AKRX: 37.68 (+2.25), FRGI: 56.43 (-0.24), BABA: 114.84 (-3.36)

Akorn drops after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 12:20PM CST

AKRX: 37.68 (+2.25)

Video: Akorn Reports 'Messy' Quarter, Slamming Stock
at Investor's Business Daily - Thu Nov 06, 12:19PM CST
Generic-drug maker and IBD 50 stock Akorn (AKRX) on Thursday reported Q3 results complicated by accounting issues, sending the stock down nearly 11% in afternoon trade on the stock market today . The company's revenue totaled $132.7 million, up 62%...
AKRX: 37.68 (+2.25)

Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars
at Investor's Business Daily - Thu Nov 06, 9:41AM CST
Stocks twisted opening gains into thin losses Thursday, as economic news and company reports fed the bulk of early action. The S&P 500 dipped 0.2%. The Nasdaq hovered a fraction into the red and the Dow Jones industrial average held effectively flat....
WFM: 46.72 (-0.76), TSLA: 251.70 (+2.60), AAP: 146.00 (-0.27), AKRX: 37.68 (+2.25), SLXP: 96.99 (+1.44), DIS: 90.49 (+0.59), GNW: 9.30 (+0.50), CDW: 32.57 (+0.10), NVDA: 19.55 (-0.10), QCOM: 70.65 (+0.36), GNRC: 41.94 (+0.19), LOCO: 34.50 (-0.99), DATA: 82.59 (-0.86)

Akorn (AKRX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 8:55AM CST

AKRX: 37.68 (+2.25)

Akorn reports 3Q loss
Automated Insights - Thu Nov 06, 6:51AM CST
LAKE FOREST, Ill. (AP) _ Akorn Inc. (AKRX) on Thursday reported a loss of $11.7 million in its third quarter.
AKRX: 37.68 (+2.25)

Akorn beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:49AM CST

AKRX: 37.68 (+2.25)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 239

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Skyline Builders Group Secures $23.9 Million Funding for Growth

Updated Category News Views 271

Skyline Builders Group Holding Limited's Latest Private Placement Skyline Builders Group Holding Limited (NASDAQ: SKBL), a prominent civil engineering services provider in Hong Kong, has made headlines recently with its announcement of a significant funding initiative. The company is moving forward with a private placement that aims to raise an impressive $23.9 million....

Continue Reading
Target Hospitality's Q1 Results Highlight Strategic Growth Path

Updated Category News Views 124

Target Hospitality Delivers Impressive First Quarter Results Target Hospitality Corp. (NASDAQ: TH), a leading provider of integrated modular accommodations and hospitality services, has showcased its resilience and strategic growth during the first quarter. The company announced substantial results for its operations that concluded on March 31, 2025, marked by a keen...

Continue Reading
Why Estero, FL Is the New Hotspot for Relocation

Updated Category News Views 6

Escaping the Cold: A Migration to Estero It seems Estero, FL is becoming the new darling for those tired of shoveling snow. Marty Pecoraro from MP Realty Group spills the beans on why this sunny spot is pulling in folks from all corners. The Draw of a Warmer Lifestyle Forget just chasing sunshine. The trend of moving to Estero isn't about lounging in the sun like a...

Continue Reading
Pega's Global Expansion of Developer Training for Future Pros

Updated Category News Views 53

Pegasystems Inc (NASDAQ: PEGA) kicked off a major expansion of its Pega University Program, trying to tackle the escalating demand for software developers. This initiative had already shown promise in India and aimed to spread across North America, Europe, and Asia Pacific. Back then, the industry was choking on a talent shortage that had firms scrambling; projections...

Continue Reading
Pony AI's Robotaxi Service Revolutionizes Urban Transportation

Updated Category News Views 262

Introduction to Pony AI's Innovative Robotaxi Services Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY), renowned for its pioneering solutions in autonomous mobility, has marked a new chapter in urban transportation. The introduction of paid robotaxi services in the heart of Guangzhou is a groundbreaking move, connecting residents and travelers to major...

Continue Reading